EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study)

C Lammi, E Ottaviano, G Fiore, C Bollati, L d'Adduzio, M Fanzaga, C Ceccarani, S Vizzuso, G Zuccotti, E Borghi, E Verduci

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02444-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von C Lammi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Milan, 20133, Milan, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Docosahexaenoic Acids, Pediatric Obesity, Anti-Inflammatory Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Università degli Studi di Milano.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Docosahexaenoic acid (DHA) is a long-chain omega‐3 polyunsaturated fatty acid. We investigated the dual health ability of DHA to modulate gut microbiota in children with obesity and to exert anti-inflammatory activity on human intestinal Caco-2 cells.

Methods

In a pilot study involving 18 obese children (8–14 years), participants received a daily DHA supplement (500 mg/day) and dietary intervention from baseline (T0) to 4 months (T1), followed by dietary intervention alone from 4 months (T1) to 8 months (T2). Fecal samples, anthropometry, biochemicals and dietary assessment were collected at each timepoint. At preclinical level, we evaluated DHA’s antioxidant and anti-inflammatory effects on Caco-2 cells stimulated with Hydrogen peroxide (H 2 O 2 ) and Lipopolysaccharides (LPS), by measuring also Inducible nitric oxide synthase (iNOS) levels and cytokines, respectively.

Results

Ten children were included in final analysis. No major changes were observed for anthropometric and biochemical parameters, and participants showed a low dietary compliance at T1 and T2. DHA supplementation restored the Firmicutes/Bacteroidetes ratio that was conserved also after the DHA discontinuation at T2. DHA supplementation drove a depletion in Ruminococcaceae and Dialisteraceae, and enrichment in Bacteroidaceae , Oscillospiraceae, and Akkermansiaceae . At genus level, Allisonella was the most decreased by DHA supplementation. In Caco-2 cells, DHA decreased H 2 O 2 -induced reactive oxygen species (ROS) and nitric oxide (NO) production via iNOS pathway modulation. Additionally, DHA modulated proinflammatory (IL-1β, IL-6, IFN-γ, TNF-α) and anti-inflammatory (IL-10) cytokine production in LPS-stimulated Caco-2 cells.

Conclusion

An improvement in gut dysbiosis of children with obesity seems to be triggered by DHA and to continue after discontinuation. The ability to modulate gut microbiota, matches also with an anti-inflammatory effect of DHA on Caco-2 cells. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDocosahexaenoic AcidsPediatric ObesityAnti-Inflammatory AgentsHumansChildCaco-2 CellsMaleAdolescentFemalePilot ProjectsDietary Supplements

Stichwörter der Autor:innen

Anti-inflammatory activityAntioxidant effectCaco-2 cellsChildhood obesityDocosahexaenoic acidGut microbiota

Substanzen

Docosahexaenoic AcidsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Milan, 20133, Milan, Italy.
  • Department of Health Sciences, University of Milan, 20142, Milan, Italy.
  • Department of Health Sciences, University of Milan, 20142, Milan, Italy. giulia.fiore@unimi.it.
  • Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Via Lodovico Castelvetro 32, 20154, Milan, Italy. giulia.fiore@unimi.it.
  • Institute for Biomedical Technologies, CNR, Segrate, Italy.
  • Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Via Lodovico Castelvetro 32, 20154, Milan, Italy.

Förderung

  • NextGenerationEU
  • Università degli Studi di Milano

Zitieren

APA

Lammi, C., Ottaviano, E., Fiore, G., Bollati, C., d'Adduzio, L., Fanzaga, M., Ceccarani, C., Vizzuso, S., Zuccotti, G., Borghi, E., & Verduci, E. (2024). Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study). Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02444-w

Vancouver

Lammi C, Ottaviano E, Fiore G, Bollati C, d'Adduzio L, Fanzaga M, et al. Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study). Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02444-w

BibTeX
@article{Lammi2024,
  author = {Lammi, C and Ottaviano, E and Fiore, G and Bollati, C and d'Adduzio, L and Fanzaga, M and Ceccarani, C and Vizzuso, S and Zuccotti, G and Borghi, E and Verduci, E},
  title = {Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study)},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02444-w}
}
Kostenlos starten →